← Back to all recallsDRUG RECALL
Trokendi XR 25mg Capsules
Supernus Pharmaceuticals is recalling Trokendi XR 25mg capsules due to failed dissolution specifications.
What to do
Contact your healthcare provider or pharmacist to discuss alternative treatment options and return the affected medication to the place of purchase.
Why it was recalled
Supernus Pharmaceuticals is recalling Trokendi XR (topiramate extended-release) 25mg capsules due to failed dissolution specifications. This recall affects the 30-count bottle size.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Trokendi XR, topiramate extended-release capsules
- Strength
- 25 mg
- NDC / UPC
- NDC 17772-101-30
Official source
← Back to all recalls
Editorial summary by Recall Canary · last updated 2026-07-20 · primary source: U.S. Food and Drug Administration